Antidepressants for smoking cessation

Cited by (1,000)

Items 801–900 of 1,000

1. Interventions for Midlife Smoking Cessation: A Literature Review
   Amy Dawel, Kaarin Jane Anstey · 2011 · Australian Psychologist
2. Smoking cessation and serious mental illness: a service evaluation of a drop‐in stop smoking clinic on an acute in‐patient unit
   Debbie Robson, Fiona Cole, Sally Jalasi, Bhimla Boojharut, Sharon M. Rosenbaum Smith, Sibi Thompson, Martin Jones, Mark Haddad · 2012 · Journal of Clinical Nursing
3. Evidence-Based Smoking Cessation for College Students
   Karen M. Butler, Amanda Fallin‐Bennett, Stanley Lee Ridner · 2011 · Nursing Clinics of North America
4. Postnatal Metabolic and Reproductive Consequences of Fetal and Neonatal Exposure to the Smoking Cessation Drug Bupropion
   Nicole E. De Long, Jillian R. Hyslop, Catherine J. Nicholson, Katherine Mary Morrison, Hertzel C. Gerstein, Alison C. Holloway · 2013 · Reproductive Sciences
5. Psycho- und Pharmakotherapie bei schädlichem Tabakgebrauch und -abhängigkeit
   Anil Batra, Kay Uwe Petersen, Eva Hoch, Karl F Mann, Christoph Bernhard Kröger, C. Schweizer, Andreas Jähne, Tobias Rüther, Norbert Thürauf, Stephan Mühlig · 2015 · Der Nervenarzt
6. A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation
   Dan Xiao, Mitchell L. Kotler, Jian Kang, Chen Wang · 2019 · Journal of Addiction Medicine
7. Effects of bupropion and SSRI antidepressants on leg movement activity and chin muscle tone during sleep in adolescents
   Lourdes M. DelRosso, Maria Paola Mogavero, Amy Fickensher, Oliviero Bruni, Carlos Hugh Schenck, Raffaele Ferri · 2022 · Journal of Clinical Sleep Medicine
8. Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial
   Laurie A. Zawertailo, Tara Mansoursadeghi-Gilan, Helena Zhang, Sarwar Hussain, Bernard Le Foll, Peter L. Selby · 2018 · JMIR Research Protocols
9. Smoking dependence and anxio-depressive disorders in Tunisian smokers attending the smoking cessation clinic in a university hospital
   Héla Ghali, Oussama Ben Rejeb, Sihem Ben Fredj, Salwa Khéfacha, Lamine Dhidah, M. Ben Rejeb, Houyem Said Latiri · 2019 · Journal of the Egyptian Public Health Association
10. Situational temptation scores and smoking cessation in general care.
    Lutz Philipp Breitling, Dorothee Twardella, Elke Raum, Hermann Brenner · 2009 · Psychology of Addictive Behaviors
11. Association between depressive mood and cigarette smoking in a large Italian sample of smokers intending to quit: implications for treatment
    Fabio Lugoboni, Gianluca Quaglio, Benedetta Pajusco, Paolo Mezzelani, Alessandro Lechi · 2007 · Internal and Emergency Medicine
12. Smoking cessation treatment by Dutch respiratory nurses: Reported practice, attitudes and perceived effectiveness
    Daniel Kotz, Walter J.M. van Litsenburg, R. van Duurling, Onno C. P. van Schayck, Geertjan Wesseling · 2007 · Patient Education and Counseling
13. Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study
    Sandipan Bhattacharjee, Majed S. Al Yami, Sawsan M. Kurdi, David Rhys Axon · 2018 · BMC Psychiatry
14. Non-Atherosclerotic Vascular Disease in the Young
    Osvaldo Camilo, Larry B. Goldstein · 2005 · Journal of Thrombosis and Thrombolysis
15. Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence.
    Joseph W. Ditre, Jason A. Oliver, Hugh Myrick, Scott Henderson, Michael E. Saladin, David J. Drobes · 2012 · Experimental and Clinical Psychopharmacology
16. “Tobacco dependence treatment makes no sense because”…: Rebuttal of commonly-heard arguments against providing tobacco dependence treatment in the hospital setting
    James Balmford, Jens A. Leifert, Andreas Jaehne · 2014 · BMC Public Health
17. Personalized teleprehabilitation in elective cardiac surgery: a study protocol of the Digital Cardiac Counselling randomized controlled trial
    Bart Scheenstra, Chanu Mohansingh, Bart Chateau Bongers, Sandra Dahmen, Yvonne I M S Wouters, Antoine F. Lenssen, Phil Geerlings, Henriette F M Knols, Sander M. J. van Kuijk, Merel Kimman et al. · 2021 · European Heart Journal - Digital Health
18. Preguntas y respuestas en tabaquismo
    Juan Diego Álvarez Mavárez, Rosa Mirambeaux Villalona, Beatriz Raboso Moreno, Gonzalo Segrelles Calvo, Eva Cabrera César, Eva Belén de Higes-Martínez · 2023 · Open Respiratory Archives
19. Translational research in addiction: Toward a framework for the development of novel therapeutics
    Neil E. Paterson · 2011 · Biochemical Pharmacology
20. Pharmacologic risk factor management in peripheral arterial disease: A vade mecum for vascular surgeons
    Thomas F. Rehring, Ryan S. Stolcpart, Harris W. Hollis · 2008 · Journal of Vascular Surgery
21. Long-term efficacy and safety of varenicline for smoking cessation: a systematic review and meta-analysis of randomized controlled trials
    Yubei Huang, Weiqin Li, Yang Li, Yuan Zhu Jiang, Yangfeng Wu · 2012 · Journal of Public Health
22. Ethical concerns about non-active conditions in smoking cessation trials and methods to decrease such concerns
    John R. Hughes · 2008 · Drug and Alcohol Dependence
23. Richtlinien der Tabakentwöhnung Stand 2010
    Alfred Lichtenschopf · 2011 · Wiener klinische Wochenschrift
24. Meanings of consumption and abandonment: understanding smoking cessation symbolism
    Maribel Carvalho Suarez · 2014 · BAR - Brazilian Administration Review
25. Smoking cessation treatment for COPD smokers: the role of pharmacological interventions
    Carlos Andrés Jimenez-Ruiz, K.O. Fagerström · 2015 · Monaldi Archives for Chest Disease
26. Health professional advice, use of medications and smoking cessation: A population-based prospective cohort study
    Bo Zhang, Michael Chaiton, Lori M. Diemert, Susan J. Bondy, Karen S Brown, Roberta G. Ferrence · 2016 · Preventive Medicine
27. Psychological Treatments of Substance Misuse and Dependence
    H. Valerie Curran, Colin Drummond · 2007 · Elsevier eBooks
28. “Cold turkey” or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer
    Samir S. Khariwala, Nathan Rubin, Irina S Stepanov, Nicole L. Nollen, Jasjit S. Ahluwalia, Heather H. Nelson, Dorothy K. Hatsukami · 2019 · Head & Neck
29. The Association of Current Tobacco Status With Pain and Symptom Severity in Fibromyalgia Patients
    Ivana T. Croghan, Ryan T. Hurt, Ravindra Ganesh, Ojas Bhagra, Karen M. Fischer, Ann Vincent, James Taylor Hays, Dennis M. Bierle, Darrell R. Schroeder, Debbie L. Fuehrer et al. · 2021 · Mayo Clinic Proceedings Innovations Quality & Outcomes
30. Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD)
    Daniel Kotz, Marcus J. H. Huibers, Rein Vos, Onno C. P. van Schayck, Geertjan Wesseling · 2007 · Medical Hypotheses
31. Pharmacologic Interventions for Smoking Cessation
    Robin L. Corelli, Karen Suchanek Hudmon · 2006 · Critical Care Nursing Clinics of North America
32. The Epidemiology of Tobacco Use and Dependence
    Karen Suchanek Hudmon, Briseis Aschebrook‐Kilfoy, Alexander V. Prokhorov · 2006 · Critical Care Nursing Clinics of North America
33. Efficacy of antidepressants in the treatment of chronic nonspecific low back pain: a systematic review and meta-analysis
    Márcio José Leão Nunes Filho, Eduardo Silva Reis Barreto, César Romero Antunes Júnior, Vinícius Borges Alencar, Liliane Lins-Kusterer, Liana Maria Tôrres de Araújo Azi, Durval Campos Kraychete · 2024 · Pain Management
34. CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence
    Yawo Akrodou · 2015 · Scientifica
35. The Stop-Tabac smartphone application for smoking cessation: study protocol for a randomized controlled trial in the general population
    Jean‐François Etter, Yasser Khazaal · 2020 · Trials
36. 5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence
    Guy A. Higgins, Edward M. Sellers · 2021 · Progress in brain research
37. Behaviour change intervention for smokeless tobacco (ST) cessation delivered through dentists within a dental setting: a feasibility study protocol
    Shaista Rasool, Richard Holliday, Zohaib Khan, Fiona Dobbie, Linda Bauld · 2022 · BDJ Open
38. Antidepressant Use and Lung Cancer Risk and Survival: A Meta-analysis of Observational Studies
    Eunkyung Lee, Yongho Park, David Li, Alice Rodriguez-Fuguet, Xiaochuan Wang, Wen Cai Zhang · 2023 · Cancer Research Communications
39. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement
    Paul M. Cinciripini, Charles E. Green, Sanjay S. Shete, Jennifer A. Minnix, Jason D. Robinson, Yong Cui, Seokhun Kim, George Kypriotakis, Diane Beneventi, Janice A. Blalock et al. · 2024 · JAMA
40. Effects of rapid smoking on post‐cessation urges to smoke
    Hayden J. McRobbie, Peter Hájek · 2007 · Addiction
41. Pharmacotherapy for tobacco cessation: Nicotine agonists, antagonists, and partial agonists
    Maher Karam‐Hage, Paul M. Cinciripini · 2007 · Current Oncology Reports
42. Smoking Cessation Interventions for Lung Cancer Patients
    Kristin Carson‐Chahhoud, Zafar Ahmad Usmani, Thomas A. Robertson, Satya Mysore, Malcolm P Brinn · 2013 · Lung Cancer Management
43. Therapeutic Strategies to Optimize the Efficacy of Nicotine Replacement Therapies
    Ivan Berlin · 2009 · COPD Journal of Chronic Obstructive Pulmonary Disease
44. Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness
    Joelle C. Ferron, Timothy S. Devitt, Gregory J. McHugo, Jessica A. Jonikas, Judith Α. Cook, Mary F. Brunette · 2016 · Community Mental Health Journal
45. When There Is Not Enough Evidence and When Evidence Is Not Enough: An Australian Indigenous Smoking Policy Study
    Daniel Vujcich, Mike Rayner, Steven E. Allender, Ray M. Fitzpatrick · 2016 · Frontiers in Public Health
46. Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study
    Joel Monárrez‐Espino, Maria Rosaria Galanti, Jenny Hansson, Imre Janszky, Karin C Söderberg, Jette Möller · 2017 · Nicotine & Tobacco Research
47. More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
    Megan Jo Moerke, Lance Richard McMahon, Jenny L. Wilkerson · 2020 · Pharmacological Reviews
48. Population-based smoking cessation strategies: a summary of a select group of evidence-based reviews.
    2010 · Europe PMC (PubMed Central)
49. Ongoing tobacco use in women who experience homelessness and unstable housing: A prospective study to inform tobacco cessation interventions and policies
    Elise D. Riley, Kevin Delucchi, Sara Rubin, Sheri D. Weiser, Maya Vijayaraghavan, Kara L. Lynch, Janice Y. Tsoh · 2021 · Addictive Behaviors
50. Contribution of Animal Models and Preclinical Human Studies to Medication Development for Nicotine Dependence
    Athina Markou, Cristiano Chiamulera, Robert West · 2008 · Elsevier eBooks
51. Trajectories of smoking behavior as a function of mood and satisfaction with life: What matters most?
    Chiara Simone Haller · 2015 · Journal of Affective Disorders
52. Evaluation of Face-to-Face Courses in Behavioural Support for Stop Smoking Practitioners
    Leonie S. Brose, Robert West, Susan Michie, Andy McEwen · 2012 · The Journal of Smoking Cessation
53. Pharmacological treatment of addiction
    Ben J. Watson, Anne R. Lingford-Hughes · 2007 · Psychiatry
54. Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence
    Teresa M. Leyro, Erin Crew, Susan W. Bryson, Anna Lembke, Steffani R. Bailey, Judith J. Prochaska, Lisa Henriksen, Stephen P. Fortmann, Joel D. Killen, Diana T. Killen et al. · 2016 · BMJ Open
55. Strategies for smoking cessation: what is new and what works?
    K. Michael Cummings, Martin Christopher Mahoney · 2008 · Expert Review of Respiratory Medicine
56. Nurse consultation support to primary care practices to increase delivery of health behavior services
    Jodi Summers Holtrop, Steven A. Dosh, Trissa Torres, Anita K. Arnold, Jeanne Baumann, Linda L. White, Pramod K. Pathak · 2009 · Applied Nursing Research
57. Tratamiento de sustitución de nicotina frente a reducción progresiva en la deshabituación tabáquica
    Teodor Marcos, Teresa Godás, Josep Corominas · 2004 · Medicina Clínica
58. Tratamento da Fase Aguda do Acidente Vascular Cerebral
    Gagliardi Rj, Rosa Martíns · 2002
59. Pharmacologic Therapy for Nicotine Addiction
    Arthur C. DeGraff · 2002 · CHEST Journal
60. The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review
    Grunze, Anna, Mosolov, Sergey, Grunze, Heinz, Born, Christoph · 2023 · Frontiers in Psychiatry
61. Smoking Cessation Strategies After Acute Coronary Syndrome
    Anum Nazir, Smrthi Shetty Ujjar, M. Seddiki, Mala Jheinga, Lampson M. Fan · 2025 · Journal of Clinical Medicine
62. PRECLINICAL STUDY: Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice
    Carmen Gómez, Carmen Carrasco, Rosa Redolat · 2008 · Addiction Biology
63. A Cost–Benefit Analysis of the Outpatient Smoking Cessation Services in Taiwan From a Societal Viewpoint
    Pei‐Ching Chen, Yue-Chune Lee, Shih-Tzu Tsai, Chih-Kuan Lai · 2011 · Nicotine & Tobacco Research
64. An innovative team-based stop smoking competition among Māori and Pacific Island smokers: rationale and method for the study and its evaluation
    Marewa Glover, Amber Bosman, Annemarie Wagemakers, Anette Kira, Chris Paton, Nathan Cowie · 2013 · BMC Public Health
65. Time trends in access to smoking cessation support for people with depression or severe mental illness: a cohort study in English primary care
    Milena Falcaro, David Osborn, Joseph Hayes, Lisa M.Z. Couperthwaite, Scott Weich, Kate R Walters · 2021 · BMJ Open
66. High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes
    Michelle Kassner, Jason Brek Eaton, Nanyun Tang, Joachim L. Petit, Nathalie Meurice, Hongwei Holly Yin, Paul Whiteaker · 2022 · SLAS DISCOVERY
67. Appetitive Pavlovian conditioning of the stimulus effects of nicotine enhances later nicotine self‐administration
    Scott T. Barrett, Allissa T. Flynn, Y. Wendy Huynh, Rick A. Bevins · 2022 · Journal of the Experimental Analysis of Behavior
68. Global prevalence of smoking among individuals with obsessive-compulsive disorder and symptoms: a systematic review and meta-analysis
    Mehdi Akbari, Mohammad Seydavi, Gregory S. Chasson, Adam Matthew Leventhal, Maria Izabel Lockwood · 2022 · Health Psychology Review
69. Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta‐analysis
    Xinxin Deng, Xue Shang, Kangle Guo, Liying Zhou, Yongsheng Wang, Yanan Wu, Shanshan Liang, E Fenfen, Wendi Liu, Ziyi Wang et al. · 2023 · Addiction Biology
70. Update on smoking cessation therapies
    Deirdre A. Glynn, John F. Cryan, Pauline Kent, Robert A. Flynn, Marcus Peter Kennedy · 2009 · Advances in Therapy
71. Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: A growth curve modeling approach.
    Haruka Minami, Christopher W. Kahler, Erika Litvin Bloom, Mark A. Prince, Ana M. Abrantes, David R. Strong, RAYMOND S. NIAURA, Ivan W. Miller, Kathleen M. Palm Reed, Lawrence H. Price et al. · 2014 · Experimental and Clinical Psychopharmacology
72. Potential Conflict of Interest and Bias in the RACGP's Smoking Cessation Guidelines: Are GPs Provided with the Best Advice on Smoking Cessation for their Patients?
    Ross MacKenzie, Wendy Rogers · 2015 · Public Health Ethics
73. A Comparison of the Effectiveness of Varenicline and Transdermal Nicotine Patch in Outpatients Following a Standardized Smoking Cessation Program in Southern Taiwan
    Shu-Chun Hsueh, Kuang-Chieh Hsueh, Ming-Yueh Chou, Ming‐Shium Tu · 2012 · Evaluation & the Health Professions
74. Reduction in and Preventive Effects for Oral-Cancer Risk with Antidepressant Treatment
    Chia‐Min Chung, Tzer‐Min Kuo, Kun‐Tu Yeh, Chien‐Hung Lee, Ying‐Chin Ko · 2021 · Journal of Personalized Medicine
75. Smoking, Work Stress, and Barriers to Participation in HMO Smoking Cessation Treatment Among Transit Workers: Focus Group Results
    Carol B. Cunradi, Roland S. Moore, Robynn S. Battle, Valerie B. Yerger · 2015 · Journal of Workplace Behavioral Health
76. Public Attitudes Toward the Treatment of Nicotine Addiction
    Kylie Morphett, Jayne C. Lucke, CORAL E. GARTNER, Adrian Carter, Carla Meurk, Wayne Hall · 2013 · Nicotine & Tobacco Research
77. Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers
    Peter H. Silverstone, R. Dadashova · 2012 · Annals of General Psychiatry
78. Safety of smoking cessation drugs for mentally ill patients
    Laurie A. Zawertailo · 2016 · The Lancet
79. Cost‐effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD
    Bertalan Németh, Judit Józwiak‐Hagymásy, Gábor Kovács, Attila D Kovács, Tibor Demjén, Manuel B. Huber, Kei Long Cheung, Kathryn Coyle, Adam Lester‐George, Subhash Pokhrel et al. · 2018 · Addiction
80. Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade
    Marie N. S. Gendy, Christine Ibrahim, Matthew E. Sloan, Bernard Le Foll · 2019 · Handbook of experimental pharmacology
81. Assessment of risk for food insecurity among African American urban households: utilizing cumulative risk indices and latent class analysis to examine accumulation of risk factors.
    Nicole O’Reilly, Erin R. Hager, Donna Harrington, Maureen M. Black · 2020 · PubMed Central
82. Documento de posicionamiento de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) ante las estrategias de reducción del daño del tabaco
    Carlos Andrés Jiménez Ruiz, Segismundo Solano-Reina, Eva de Higes-Martínez, Eva Cabrera-César, Raúl Sandoval-Contreras, José Ignacio de Granda‐Orive, Juan Antonio Riesco-Miranda, Jaime Signes-Costa Miñana, José Javier Lorza-Blasco, Manuel Ángel Martínez-Muñiz et al. · 2022 · Open Respiratory Archives
83. Challenges and perspectives of tobacco cessation in special groups of patients and populations
    Stamatoula Tsikrika, Siyu Dai, Aslı Görek Dilektaşlı, Paraskevi A Katsaounou, Elif Dağlı · 2023 · Breathe
84. Two-Hour Tobacco Abstinence Has No Effect on Cognitive Control in Male Patients With Nicotine Dependence: An ERP Study
    Yanling Xue, Hongliang Zhou, Chenguang Jiang, Xiaohong Liu, Zhenhe Zhou, Jun Wang · 2020 · Frontiers in Psychiatry
85. Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders
    Saki Rubaiya Talukder, Julia Lappin, Veronica Clare Boland, Hayden J. McRobbie, Ryan J. Courtney · 2021 · Tobacco Control
86. Spirometry and Smoking Cessation in Primary Care: The ESPIROTAB STUDY, A Randomized Clinical Trial
    Maria del Mar Rodríguez-Álvarez, Josep Roca-Antonio, Silvia Martínez-González, Victoria Vilà-Palau, Carla Chacón, Alexandre Ortega-Roca, Eulàlia Borrell-Thió, Susana Erazo, Jordi Almirall, Pere Torán‐Monserrat · 2022 · International Journal of Environmental Research and Public Health
87. Suchterkrankungen
    Karl F Mann, Michael M. Berner, Arthur Günthner · 2012 · Elsevier eBooks
88. Integrated Chronic Obstructive Pulmonary Disease Management in Primary Care
    Niels Henrik Chavannes · 2008 · Disease Management & Health Outcomes
89. Spousal Effects in Smoking Cessation: Matching, Learning, or Bargaining?
    Kerry Anne McGeary · 2013 · Eastern Economic Journal
90. Supporting smoking cessation in healthcare: obstacles in scientific understanding and tobacco addiction management
    Dianne de Korte‐de Boer, Onno C. P. van Schayck, Paul B Spiegel, Ad A. Kaptein, Alfred P. E. Sachs, Maureen Rutten‐van Mölken, Niels Henrik Chavannes, Trudi P. G. Tromp-Beelen, Rik Bes, R.H.B. Allard et al. · 2010 · Health
91. A bibliometric analysis of clinical study literature of traditional Chinese medicine therapies for smoking cessation
    Jianhua Wang, Mei Wang, Shuchun Liu, Xiao-Feng Du, Mei Han, Junfeng Liu, Wei Qin, Bin Chen, Robbert A. van Haselen, Jianping Liu · 2018 · Tobacco Induced Diseases
92. Smoking Cessation
    Manish S. Patel, Sheetal B. Patel, Michael B. Steinberg · 2021 · Annals of Internal Medicine
93. A Comprehensive Approach to Tobacco Dependence Interventions
    Stephen R. Baldassarri, Benjamin A. Toll, Frank T. Leone · 2015 · The Journal of Allergy and Clinical Immunology In Practice
94. A Systematic Analysis of Candidate Genes Associated with Nicotine Addiction
    Meng Liu, Xia Li, Rui Fan, Xinhua Liu, Ju Wang · 2015 · BioMed Research International
95. Evidence and decision making: tobacco control policy and legislation in Vietnam
    Hideki Higashi, Tuan A. Khuong, Anh Duc Ngo, Peter Hill · 2012 · The International Journal of Health Planning and Management
96. Pharmakologische Rückfallprävention bei Alkohol- und Tabakabhängigkeit
    Alexander Diehl, Karl F Mann · 2006 · Der Internist
97. Troubles psychotiques aigus liés au bupropion : revue de la littérature
    Thierry Javelot, Hervé Javelot, Alexandre Baratta, Luisa Weiner, Michaël Messaoudi, Patrick Lemoine · 2010 · L Encéphale
98. Management of abdominal aortic aneurysms
    Jennifer M. Dehlin, Gilbert R. Upchurch · 2005 · Current Treatment Options in Cardiovascular Medicine
99. Smoking Cessation in Hospital Workers
    Cristina Martínez, José María Martínez-Sánchez, Montse Ballbè, Gemma Nieva, Marcela Fu, Montse Puig, Esther Carabasa, Josep Maria Sánchez-García, Esteve Saltó, Esteve Fernández · 2011 · Cancer Nursing
100. The novel nicotinic receptor antagonist, N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [3H]norepinephrine overflow from rat hippocampal slices
     Andrew M. Smith, Gurpreet K. Dhawan, Zhenfa Zhang, Kiran Babu Siripurapu, Peter Anthony Crooks, Linda P. Dwoskin · 2009 · Biochemical Pharmacology